Patient Evidence

MPE’s patient evidence workstream was created to generate evidence to better understand and articulate patients’ perspectives, influence decision-makers and use evidence as a driving force for progress across our strategic goals.

Patient evidence ensures that patients’ experiences and needs are robustly captured through research that identifies gaps in care, quality and treatments, and the barriers to access and equality. Our patient evidence provides credible, data-driven insights that can help fill gaps in the clinical evidence and shape decisions to reflect the needs and priorities of patients.

Our strategic goal for research

We will lead the development of robust patient evidence to improve experiences, outcomes and access for myeloma patients and their families. Our research will be conducted under these themes:

Learn more about our research strategy, and the work we do within these themes, in the document below.

In addition to conducting our own research, we collaborate on external projects with patient and medical organisations, universities, clinical teams, industry partners and regulatory bodies.  Please get in touch at research@mpeurope.org if you have a research project you would like to discuss or any questions about the Patient Evidence workstream. We are interested in hearing your views and in future research collaborations.

If you are a myeloma patient, or family member of a patient with myeloma, and are interested in becoming involved in future research projects please contact us at research@mpeurope.org.